Skip to main content
Top
Published in: Journal of General Internal Medicine 9/2019

01-09-2019 | Colonoscopy | Original Research

Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients

Authors: Katelyn K. Jetelina, MPH, PhD, Joshua S. Yudkin, MPH, Stacie Miller, RN, MSN, MPH, Emily Berry, MSPH, Alicea Lieberman, MPH, Samir Gupta, MD, MSCS, Bijal A. Balasubramanian, MBBS, PhD

Published in: Journal of General Internal Medicine | Issue 9/2019

Login to get access

Abstract

Background

For colorectal cancer (CRC) screening to improve survival, patients with an abnormal fecal immunochemical test (FIT) must follow-up with a diagnostic colonoscopy. Adherence to follow-up is low and patient-level barriers for suboptimal adherence have yet to be explored.

Objective

To characterize barriers for non-completion of diagnostic colonoscopy after an abnormal FIT reported by under- and uninsured patients receiving care in a safety-net health system.

Design

A longitudinal, cohort study of CRC screening outreach to 8565 patients using mailed FIT kits. Patients with abnormal FIT results received telephonic navigation to arrange for a no-cost diagnostic colonoscopy.

Patients

Adults aged 50–64 years receiving care at a North Texas safety-net health system.

Approach

Descriptive analyses characterized the patient sample and reasons for lack of follow-up after abnormal FIT over the 3-year outreach program. Thematic qualitative analyses characterized reasons for lack of follow-up with a colonoscopy after the abnormal FIT.

Key Results

Of 689 patients with an abnormal FIT, 45% (n = 314) did not complete a follow-up colonoscopy. Among the 314 non-completers, 184 patients reported reasons for not completing a follow-up colonoscopy included health insurance-related challenges (38%), comorbid conditions (37%), social barriers such as transportation difficulties and lack of social support (29%), concerns about FIT/colonoscopy process (12%), competing life priorities (12%), adverse effects of bowel preparation (3%), and poor health literacy (3%). Among the 314 non-completers, 131 patients did not report a barrier, as 51% reported that that had completed a previous colonoscopy in the past 10 years, 10% refused with no reason, and 10% were never reached by phone.

Conclusions

Future studies aimed at improving FIT screening and subsequent colonoscopy rates need to address the unique needs of patients for effective and sustainable screening programs.

Trial Registration

Literature
1.
go back to reference Howlader NNA, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. https://seer.cancer.gov/csr/1975_2014/, Accessed February 19, 2019. Howlader NNA, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. https://​seer.​cancer.​gov/​csr/​1975_​2014/​, Accessed February 19, 2019.
2.
go back to reference U.S. Preventive Services Task Force. Final Recommendation Statement: Colorectal Cancer: Screening. Washington, DC; 2013. U.S. Preventive Services Task Force. Final Recommendation Statement: Colorectal Cancer: Screening. Washington, DC; 2013.
3.
go back to reference McLachlan S-A, Clements A, Austoker J. Patients’ experiences and reported barriers to colonoscopy in the screening context—A systematic review of the literature. Patient Educ Couns. 2012;86(2):137–146.CrossRef McLachlan S-A, Clements A, Austoker J. Patients’ experiences and reported barriers to colonoscopy in the screening context—A systematic review of the literature. Patient Educ Couns. 2012;86(2):137–146.CrossRef
4.
go back to reference Sultan S, Partin MR, Shah P, et al. Barriers and facilitators associated with colonoscopy completion in individuals with multiple chronic conditions: a qualitative study. Patient Prefer Adherence. 2017;11:985–994.CrossRef Sultan S, Partin MR, Shah P, et al. Barriers and facilitators associated with colonoscopy completion in individuals with multiple chronic conditions: a qualitative study. Patient Prefer Adherence. 2017;11:985–994.CrossRef
5.
go back to reference Selby K, Baumgartner C, Levin TR, et al. Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review. Ann Intern Med. 2017;167(8):565–575.CrossRef Selby K, Baumgartner C, Levin TR, et al. Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review. Ann Intern Med. 2017;167(8):565–575.CrossRef
6.
go back to reference Corley DA, Jensen CD, Quinn VP, et al. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis. JAMA. 2017;317(16):1631–1641.CrossRef Corley DA, Jensen CD, Quinn VP, et al. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis. JAMA. 2017;317(16):1631–1641.CrossRef
7.
go back to reference Heavener T, Jaeger V, Stephenson K, McStay F, Sing T. Diagnostic colonoscopy following abnormal FIT results: A quality improvement analysis. J Clin Oncol. 2018;36(4_suppl):568–568.CrossRef Heavener T, Jaeger V, Stephenson K, McStay F, Sing T. Diagnostic colonoscopy following abnormal FIT results: A quality improvement analysis. J Clin Oncol. 2018;36(4_suppl):568–568.CrossRef
8.
go back to reference Issaka RB, Singh MH, Oshima SM, et al. Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System. Am J Gastroenterol. 2017;112(2):375–382.CrossRef Issaka RB, Singh MH, Oshima SM, et al. Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System. Am J Gastroenterol. 2017;112(2):375–382.CrossRef
9.
go back to reference Gupta S, Sussman DA, Doubeni CA, et al. Challenges and Possible Solutions to Colorectal Cancer Screening for the Underserved. JNCI: J Natl Cancer Inst. 2014;106(4):dju032.CrossRef Gupta S, Sussman DA, Doubeni CA, et al. Challenges and Possible Solutions to Colorectal Cancer Screening for the Underserved. JNCI: J Natl Cancer Inst. 2014;106(4):dju032.CrossRef
10.
go back to reference Martin J, Halm EA, Tiro JA, et al. Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System. Am J Med.130(1):93.e91–93.e97.CrossRef Martin J, Halm EA, Tiro JA, et al. Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System. Am J Med.130(1):93.e91–93.e97.CrossRef
11.
go back to reference O’Malley AS, Beaton E, Yabroff KR, Abramson R, Mandelblatt J. Patient and provider barriers to colorectal cancer screening in the primary care safety-net. Prev Med. 2004;39(1):56–63.CrossRef O’Malley AS, Beaton E, Yabroff KR, Abramson R, Mandelblatt J. Patient and provider barriers to colorectal cancer screening in the primary care safety-net. Prev Med. 2004;39(1):56–63.CrossRef
12.
go back to reference Gupta S, Miller S, Koch M, et al. Financial incentives for promoting colorectal cancer screening: a randomized, comparative effectiveness trial. Am J Gastroenterol. 2016;111(11):1630–1636.CrossRef Gupta S, Miller S, Koch M, et al. Financial incentives for promoting colorectal cancer screening: a randomized, comparative effectiveness trial. Am J Gastroenterol. 2016;111(11):1630–1636.CrossRef
13.
go back to reference Crabtree BF, Miller WL. Doing qualitative research, Second edition. Thousand Oaks, CA: SAGE Publications; 1999. Crabtree BF, Miller WL. Doing qualitative research, Second edition. Thousand Oaks, CA: SAGE Publications; 1999.
14.
go back to reference Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59(01):62–68.CrossRef Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59(01):62–68.CrossRef
15.
go back to reference Beeker C, Kraft JM, Southwell BG, Jorgensen CM. Colorectal Cancer Screening in Older Men and Women: Qualitative Research Findings and Implications for Intervention. J Community Health. 2000;25(3):263–278.CrossRef Beeker C, Kraft JM, Southwell BG, Jorgensen CM. Colorectal Cancer Screening in Older Men and Women: Qualitative Research Findings and Implications for Intervention. J Community Health. 2000;25(3):263–278.CrossRef
16.
go back to reference Lafata JE, Williams LK, Ben-Menachem T, Moon C, Divine G. Colorectal carcinoma screening procedure use among primary care patients. Cancer. 2005;104(7):1356–1361.CrossRef Lafata JE, Williams LK, Ben-Menachem T, Moon C, Divine G. Colorectal carcinoma screening procedure use among primary care patients. Cancer. 2005;104(7):1356–1361.CrossRef
17.
go back to reference Ananthakrishnan AN, Schellhase KG, Sparapani RA, Laud PW, Neuner JM. Disparities in colon cancer screening in the medicare population. Arch Intern Med. 2007;167(3):258–264.CrossRef Ananthakrishnan AN, Schellhase KG, Sparapani RA, Laud PW, Neuner JM. Disparities in colon cancer screening in the medicare population. Arch Intern Med. 2007;167(3):258–264.CrossRef
18.
go back to reference Klabunde CN, Schenck AP, Davis WW. Barriers to Colorectal Cancer Screening Among Medicare Consumers. Am J Prev Med. 2006;30(4):313–319.CrossRef Klabunde CN, Schenck AP, Davis WW. Barriers to Colorectal Cancer Screening Among Medicare Consumers. Am J Prev Med. 2006;30(4):313–319.CrossRef
19.
go back to reference Farmer MM, Bastani R, Kwan L, Belman M, Ganz PA. Predictors of colorectal cancer screening from patients enrolled in a managed care health plan. Cancer. 2008;112(6):1230–1238.CrossRef Farmer MM, Bastani R, Kwan L, Belman M, Ganz PA. Predictors of colorectal cancer screening from patients enrolled in a managed care health plan. Cancer. 2008;112(6):1230–1238.CrossRef
20.
go back to reference Guessous I, Dash C, Lapin P, Doroshenk M, Smith RA, Klabunde CN. Colorectal cancer screening barriers and facilitators in older persons. Prev Med. 2010;50(1/2):3–10.CrossRef Guessous I, Dash C, Lapin P, Doroshenk M, Smith RA, Klabunde CN. Colorectal cancer screening barriers and facilitators in older persons. Prev Med. 2010;50(1/2):3–10.CrossRef
21.
go back to reference Jones RM, Devers KJ, Kuzel AJ, Woolf SH. Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med. 2010;38(5):508–516.CrossRef Jones RM, Devers KJ, Kuzel AJ, Woolf SH. Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med. 2010;38(5):508–516.CrossRef
22.
go back to reference Redmond Knight J, Kanotra S, Siameh S, Jones J, Thompson B, Thomas-Cox S. Understanding Barriers to Colorectal Cancer Screening in Kentucky. Prev Chronic Dis. 2015;12:E95.CrossRef Redmond Knight J, Kanotra S, Siameh S, Jones J, Thompson B, Thomas-Cox S. Understanding Barriers to Colorectal Cancer Screening in Kentucky. Prev Chronic Dis. 2015;12:E95.CrossRef
Metadata
Title
Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients
Authors
Katelyn K. Jetelina, MPH, PhD
Joshua S. Yudkin, MPH
Stacie Miller, RN, MSN, MPH
Emily Berry, MSPH
Alicea Lieberman, MPH
Samir Gupta, MD, MSCS
Bijal A. Balasubramanian, MBBS, PhD
Publication date
01-09-2019
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 9/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05117-0

Other articles of this Issue 9/2019

Journal of General Internal Medicine 9/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.